Skip to content
healthcare.dev

OLANZAPINE

NDC 68462-952, OLANZAPINE, injection, powder, lyophilized, for solution, from GLENMARK PHARMACEUTICALS INC., USA.

Product NDC
68462-952
Status
Listed
Labeler
GLENMARK PHARMACEUTICALS INC., USA
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA220323
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-952 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLANZAPINE10 mg/2mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
68462-952-10684620952101 VIAL in 1 CARTON (68462-952-10) / 2 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2e709eaf-4116-4ee3-8dff-ace36181d115
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68462-952
  • NADAC price for package 68462095210

    GET /v1/drugs/nadac/68462095210

Use it

Look up 68462-952 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-952 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-952. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.